HD-6277
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for HD-6277, covering 2024-10-18 to 2024-12-13. Get the full timeline:
Most recent: Clinical Trial Update: To Assess the Efficacy and Safety of HD-6277 in Adult Patients With Inadequate Control of Type 2 Diabetes Mellitus by Diet and Exercise [Phase 2]